This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Michelle Kuhne: Innovator in Cancer Therapeutics
Introduction
Michelle Kuhne is a prominent inventor based in San Francisco, California. She has made significant contributions to the field of cancer therapeutics through her innovative research and development of antibodies.
Latest Patents
Michelle holds a patent titled "Antibodies against TIM3 and uses thereof." This patent includes antibodies that bind to the T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. The patent outlines therapeutic applications of these antibodies, particularly in the treatment of cancer. Additionally, it provides details on the cells that produce these antibodies, the polynucleotides encoding the heavy and/or light chain regions, and the vectors comprising these polynucleotides.
Career Highlights
Michelle is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research in the field of immunotherapy. Her work has been instrumental in developing new therapeutic strategies for cancer treatment.
Collaborations
Some of her notable coworkers include Xiao Min Schebye and Mark J Selby, who collaborate with her on various research projects.
Conclusion
Michelle Kuhne's innovative work in developing antibodies for cancer treatment showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options in oncology.